BACKGROUND: Acute pancreatitis is a common complication of ERCP. Several
randomized, controlled trials (RCTs) have evaluated the use of pancreatic stents in the …

Endoscopic retrograde cholangiopancreatography (ERCP) is now almost exclusively a
therapeutic modality for pancreatic as well as biliary disorders. ERCP alone or with …

Prophylaxis 1 ESGE recommends routine rectal administration of 100 mg of diclofenac or
indomethacin immediately before endoscopic retrograde cholangiopancreatography …

Endoscopic retrograde cholangiopancreatography (ERCP) is associated with a spectrum of
complications such as pancreatitis, hemorrhage, perforation, and cardiopulmonary events …

Background Pancreatic duct disruption is common and is associated with high morbidity in
cases of acute necrotizing pancreatitis (ANP). In this study, we tested the feasibility and …

Acute post-endoscopic retrograde cholangiopancreatography pancreatitis (PEP) is a feared
and potentially fatal complication that can be as high as up to 30% in high-risk patients. Pre …

Background and study aims: Urgent placement or replacement of pancreatic stents shortly
after endoscopic retrograde cholangiopancreatography (ERCP) might attenuate the course …

Endoscopic retro-grade cholangiopancreatography (ERCP) was developed in 1968 and
almost instantly gained a key role in the diagnosis and management of many biliopancreatic …

Background The effectiveness of pancreatic duct (PD) stenting in the early stages of acute
pancreatitis (AP) remains controversial. This study aimed to investigate the efficacy and …

Managing complications of ERCP poses a significant clinical challenge to endoscopists.
ERCP complications can occur even after all preventive measures, which can lead to …